Analysts: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

271.42USD
12:55pm EDT
Price Change (% chg)

$-6.87 (-2.47%)
Prev Close
$278.29
Open
$277.64
Day's High
$277.64
Day's Low
$271.36
Volume
68,696
Avg. Vol
220,530
52-wk High
$283.00
52-wk Low
$131.50

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.98 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 4
(2) OUTPERFORM 9 8 7 6
(3) HOLD 5 6 7 8
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.05 2.11 2.22

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 17 504.59 557.89 463.50 413.41
Quarter Ending Dec-13 17 527.70 604.70 425.80 450.80
Year Ending Dec-13 19 1,952.15 2,081.51 1,774.50 1,633.82
Year Ending Dec-14 19 2,462.82 2,761.90 2,136.00 1,942.56
Earnings (per share)
Quarter Ending Sep-13 14 0.98 1.50 0.64 0.88
Quarter Ending Dec-13 14 0.99 1.51 0.42 0.98
Year Ending Dec-13 15 3.92 6.37 2.59 4.20
Year Ending Dec-14 15 6.25 10.60 3.07 5.09
LT Growth Rate (%) 3 25.03 33.00 17.10 33.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 428.25 439.66 11.41 2.66
Quarter Ending Dec-12 393.56 414.60 21.04 5.35
Quarter Ending Sep-12 349.17 427.69 78.52 22.49
Quarter Ending Jun-12 259.36 304.40 45.04 17.37
Quarter Ending Mar-12 173.08 231.79 58.71 33.92
Earnings (per share)
Quarter Ending Mar-13 0.98 0.90 0.08 7.98
Quarter Ending Dec-12 1.10 1.22 0.12 10.98
Quarter Ending Sep-12 0.95 1.72 0.77 80.92
Quarter Ending Jun-12 0.27 0.70 0.43 162.76
Quarter Ending Mar-12 -0.24 0.16 0.40 -168.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 504.59 502.83 502.13 502.13 413.41
Quarter Ending Dec-13 527.70 526.03 528.60 528.60 450.80
Year Ending Dec-13 1,952.15 1,947.37 1,948.14 1,948.14 1,633.82
Year Ending Dec-14 2,462.82 2,451.96 2,475.83 2,475.83 1,942.56
Earnings (per share)
Quarter Ending Sep-13 0.98 0.98 1.04 1.04 0.88
Quarter Ending Dec-13 0.99 0.99 1.06 1.06 0.98
Quarter Ending Dec-13 3.92 3.92 3.87 3.87 4.20
Quarter Ending Dec-14 6.25 5.70 6.07 6.07 5.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 1 0 6 1
Quarter Ending Dec-13 1 0 5 2
Year Ending Dec-13 1 0 6 1
Year Ending Dec-14 1 0 2 4
Earnings
Quarter Ending Sep-13 0 0 3 2
Quarter Ending Dec-13 0 0 3 2
Year Ending Dec-13 0 0 3 1
Year Ending Dec-14 2 0 3 3

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$58.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks